Mentice Introduces Software Subscription for its VIST® Endovascular Simulation Platform

Lucida Medical (Cambridge University Spin-out) Joins GE Healthcare Edison™ Accelerator Programme

Lucida Medical was invited to join the Edison Accelerator programme for its pioneering work in helping identify prostate cancer and its exceptional development team led by Prof Evis Sala and Dr Antony Rix, both highly experienced in artificial intelligence, or AI, medical technology.

Boston Scientific Exercises Option to Acquire Farapulse, Inc.

FARAPULSE Pulsed Field Ablation (PFA) System is a non-thermal ablation system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias.  

Today Mentice AB (STO: MNTC) (simulation solutions for endovascular therapies) announced  the introduction of software subscription for its VIST® endovascular simulation platform to hospitals and health systems. By significantly reducing the upfront capital expenditure and introducing an annual software subscription, Mentice now enables clients around the world to rapidly deploy the VIST® platform under a transparent, flexible, and predictable model.

“With global health systems and hospitals experiencing significant pressures to improve productivity, reduce costs, and improve patient outcomes, we remain laser-focused on our quest to help improve endovascular procedure performance and patient outcomes through simulation,” said Göran Malmberg, CEO at Mentice. “While our VIST® platform helps our clients improve their clinical performance, the introduction of software subscription on our training modules aligns Mentice to the financial realities of a clinical practice helping our clients operationalize costs to better manage their financial performance.”

The VIST® software subscription offers Mentice clients flexible procedure selection and predictable annual pricing while it includes software updates, it eliminates hidden service support costs, and it scales based on customer need.

In addition to lower cost of entry and software updates, software subscription for the VIST® platform includes complimentary trial of new procedures, ability to exchange procedures as client-needs change, and access to a global team of software and hardware support experts.

This is the first and a significant step into Mentice’s plans to advance the value of endovascular simulation for clients worldwide.

spot_img

DON'T MISS

Trinity Health Names Mark LePage, M.D., as Senior Vice President of Medical Groups and Ambulatory Strategy

Prior to his time at IHA, LePage served as chief medical officer of Marshfield Clinic in Wisconsin

Jody Crane, MD Recognized by Modern Healthcare As One of the 50 Most Influential Clinical Executives

Dr. Crane’s work to streamline operations positioned and prepared TeamHealth and its clinicians to face the COVID-19 pandemic. Under Dr. Crane’s leadership, TeamHealth was able to maintain high levels of clinical quality throughout the rapidly changing COVID environment.

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

Subscribe to Medical Device News Magazine here.

Related Articles